SDC are often upregulated in gastric and colon cancers, but Syndecan-1 (SDC1) is upregulated only in pancreatic cancer, where it correlates with invasion of cancer and a poor prognosis (Conejo et al., 2000; Yao et al., 2019). This evidence concerns the gene SDC1 and familial pancreatic carcinoma.